Document is current

Article History

Received: 18 September 2020

Accepted: 21 December 2020

First Online: 14 January 2021

Ethics approval and consent to participate

: The study was conducted in accordance with the Good Clinical Practice Guidelines and the Declaration of Helsinki. All patients provided written informed consent before an independent witness of the research team prior to inclusion in the study. This study was approved by Local Clinical Research Ethics Committee of Galicia (CAEI). All patients provided written informed consent before an independent witness of the research team prior to inclusion in the study.

: Not applicable – this article does not contain identifying information for any patients.

: NML has received personal fees from Amgen, Sanofi, Roche, Merck, Leopharma, Celgene-BMS, Lilly, Ipsen, and Pfizer.AFM has received personal fees from Amgen, Merck, Roche, Sanofi, Lilly, Bayer, Servier, BMS, and EISAI.EMBV has received personal fees from Leopharma and Rovi.JCCG has received honoraria for advisory role from Merck, Amgen, Roche, and Sanofi.MLPA has received personal fees from Roche and Merck, and grants from Merck and Ipsen.PGV has received honoraria for consulting or advisory roles from Amgen, has participated in a speakers’ bureau for Amgen and Lilly, and has received fees for travel, accommodations, or other expenses from Amgen, Lilly, and Merck.BGS has received personal fees from Amgen, Merck, Roche, Sanofi, Servier, EISAI, Celgene, and Incyte, and non-financial support from Amgen, Merck, Roche, Sanofi, Servier, EISAI, Celgene, and Incyte.MSF has received honoraria for advisory role from Amgen, Servier, and Merck, fees as speaker’s bureau from BMS, Amgen, and Merck, and travel and educational support from Roche, Servier, and Sanofi.MCR, JCMM, MJF, ACC, CRR, DAR, MCC, YVI, ACM, FVR, SCF, and MRL declare that they have no competing interests.